AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MESOBLAST LTD

2.360

+0.0100.43%

Volume:1.99M

Turnover:4.75M

Market Cap:3.06B

PE:-23.03

High:2.440

Open:2.410

Low:2.340

Close:2.350

52wk High:3.310

52wk Low:1.880

Shares:1.30B

Float Shares:786.49M

Volume Ratio:0.76

T/O Rate:0.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.102

EPS(LYR):-0.118

ROE:-18.22%

ROA:-6.16%

PB:3.82

PE(LYR):-20.04

Loading ...

Overview Company News Filings

Mesoblast Says CEO Makes Investment to Increase Share Ownership

Mesoblast CEO Boosts Stake in Company With AU$2.7 Million Exercise of Options

MT Newswires Live

Stock Track | Mesoblast Plummets 5.14% Intraday on Profitability and Valuation Concerns Despite CEO Share Purchase

Mesoblast - CEO Exercises 1.9 Mln Options at A$1.45 Each for A$2.73 Mln

THOMSON REUTERS

Mesoblast - CEO Increases Shareholding to 80.8 Mln Shares

THOMSON REUTERS

Mesoblast Ltd-mesoblast CEO Makes Investment to Increase Share Ownership

THOMSON REUTERS

3 Founder Led Stocks With Real Management Alignment Investors May Want To Watch

Simply Wall St.

Flight Centre Stock And 2 Founder Led Australian Shares Backed By Long Term Focus

Simply Wall St.

Founder Led Australian Stocks With The Clearest Growth Story Right Now

Simply Wall St.

ASX Biggest Losers

MT Newswires Live

Founder Led Stocks For Investors Watching Australian Small Caps Closely

Simply Wall St.

Flight Centre Stock And 2 Founder Run ASX Shares Worth A Closer Look

Simply Wall St.

Mesoblast Achieves Patient Treatment Target in Phase 3 Trial of Chronic Lower Back Pain

MT Newswires Live

Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain

THOMSON REUTERS

ASX Stocks Estimated To Be Trading Below Fair Value In July 2026

Simply Wall St.

3 Australian Founder Led Stocks Backed By Strong Long Term Themes

Simply Wall St.

Stock Track | Mesoblast Soars 8.93% Intraday on Upbeat Ryoncil Cell Therapy Earnings

Australia's Mesoblast Extends Gains on Upbeat Ryoncil Cell Therapy Earnings

Founder Led Stocks With Real Skin In The Game

Simply Wall St.

Mesoblast (ASX:MSB) Is Up 8.7% After Strong Ryoncil Debut And FDA BLA Milestone - Has The Bull Case Changed?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/MSB.AU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MSB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","market":"AU","secType":"STK","nameCN":"MESOBLAST LTD","latestPrice":2.36,"timestamp":1787724720000,"preClose":2.35,"halted":0,"volume":1989383,"delay":0,"changeRate":0.004255319148936079,"nameEN":"MESOBLAST LTD","floatShares":786490638,"shares":1296862776,"eps":-0.10248079137983139,"marketStatus":"Closed","change":0.01,"latestTime":"08-26 16:12:00 AEST","open":2.41,"high":2.44,"low":2.34,"amount":4749233,"amplitude":0.042553,"askPrice":2.38,"askSize":3000,"bidPrice":2.35,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":-0.10248079137983139,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787788800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":2.35,"openAndCloseTimeList":[[1787702400000,1787724000000]],"volumeRatio":0.762795,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MSB.AU","preClose":2.35,"auctionPrice":2.36,"auctionVolume":325847,"auctionTime":1787724605214,"referencePrice":2.36,"referenceTime":1787734800825,"auction":3,"marketStatus":"盘后竞价","timestamp":1787724605214}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","floatShares":786490638,"roa":"-6.16%","roe":"-18.22%","lyrEps":-0.117778,"volumeRatio":0.762795,"shares":1296862776,"dividePrice":0,"high":2.44,"amplitude":0.042553,"preClose":2.35,"low":2.34,"week52Low":1.88,"pbRate":"3.82","psRate":"33.61","week52High":3.31,"institutionHeld":0,"latestPrice":2.36,"committee":0.538462,"eps":-0.10248079137983139,"divideRate":0,"volume":1989383,"delay":0,"ttmEps":-0.10248079137983139,"open":2.41,"prevYearClose":2.72,"prevWeekClose":2.36,"prevMonthClose":2.05,"prevQuarterClose":1.955,"fiveDayClose":2.37,"twentyDayClose":2.04,"sixtyDayClose":2.05,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSB.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"MSB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787702400000,"name":null,"time":"","dateTimestamp":1787666400000,"actualEps":null},{"date":"2025-02-26","symbol":"MSB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MSB.AU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653247434","title":"Mesoblast Says CEO Makes Investment to Increase Share Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2653247434","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653247434?lang=en_us&edition=fundamental","pubTime":"2026-07-21 09:48","pubTimestamp":1784598503,"startTime":"0","endTime":"0","summary":"July 21 (Reuters) - Mesoblast Ltd::*MESOBLAST CEO MAKES INVESTMENT TO INCREASE SHARE OWNERSHIP*CEO EXERCISES 1.9 MILLION OPTIONS AT A$1.45 EACH FOR A$2.73 MILLION*CEO INCREASES SHAREHOLDING TO 80.8 MI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nRSDby1pPR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB.AU","BK7508","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653242510","title":"Mesoblast CEO Boosts Stake in Company With AU$2.7 Million Exercise of Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2653242510","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653242510?lang=en_us&edition=fundamental","pubTime":"2026-07-21 08:52","pubTimestamp":1784595158,"startTime":"0","endTime":"0","summary":"Mesoblast  CEO Silviu Itescu increased his holdings in the company to about 80.8 million common shares through the exercise of about 1.9 million options at a price of AU$1.45 each, according to a Tuesday filing with the Australian bourse.Itescu, the company's founder, paid Mesoblast about AU$2.7 million to exercise the options, per the filing.\"The investment reflects my strong confidence in Mesoblast's continued growth trajectory and its value proposition,\" the executive said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7067","BK7501","MSB.AU","BK4139","MESO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129949977","title":"Stock Track | Mesoblast Plummets 5.14% Intraday on Profitability and Valuation Concerns Despite CEO Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1129949977","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129949977?lang=en_us&edition=fundamental","pubTime":"2026-07-21 08:27","pubTimestamp":1784593675,"startTime":"0","endTime":"0","summary":"Mesoblast Ltd's stock fell sharply by 5.14% during Tuesday's intraday trading session. The biotech company's shares experienced significant selling pressure despite recent positive insider...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653729241","title":"Mesoblast - CEO Exercises 1.9 Mln Options at A$1.45 Each for A$2.73 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2653729241","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653729241?lang=en_us&edition=fundamental","pubTime":"2026-07-21 07:54","pubTimestamp":1784591641,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUE32J856:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MESO","BK4139","MSB.AU","BK7508","BK7501","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653417252","title":"Mesoblast - CEO Increases Shareholding to 80.8 Mln Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2653417252","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653417252?lang=en_us&edition=fundamental","pubTime":"2026-07-21 07:54","pubTimestamp":1784591641,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUE32J856:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","MSB.AU","MESO","BK7067","BK7508","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653241726","title":"Mesoblast Ltd-mesoblast CEO Makes Investment to Increase Share Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2653241726","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653241726?lang=en_us&edition=fundamental","pubTime":"2026-07-21 07:54","pubTimestamp":1784591641,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUE32J856:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","MSB.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249546","title":"3 Founder Led Stocks With Real Management Alignment Investors May Want To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249546","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249546?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:21","pubTimestamp":1784578886,"startTime":"0","endTime":"0","summary":"Founder led companies can be especially interesting when markets are juggling inflation questions, energy price swings and shifting interest rate expectations, because these leaders often have their own capital, reputation and long term legacy on the line. Instead of constantly reacting to central bank headlines, you are backing people who are already deeply committed to their business plans. This Founder Led Companies screener is built to surface those opportunities, cutting through sector...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-founder-led-stocks-with-real-management-alignment-investor","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-founder-led-stocks-with-real-management-alignment-investor","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","BK7043","FLT.AU","MQG.AU","BK7067","MSB.AU","BK7042","BK7508","ISBC","BK7046","BK4211","MAQ.AU","BK7511","BK7070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652404252","title":"Flight Centre Stock And 2 Founder Led Australian Shares Backed By Long Term Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2652404252","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652404252?lang=en_us&edition=fundamental","pubTime":"2026-07-20 01:20","pubTimestamp":1784481650,"startTime":"0","endTime":"0","summary":"Founder led companies can be especially interesting when inflation is easing but energy and rate risks still influence market sentiment, because many founders tend to stay focused on long term execution regardless of short term noise. The Founder Led Companies screener is built to surface leaders who are personally invested in the outcome of their business and whose incentives are closely aligned with shareholders. In the sections ahead, you will see 3 stocks from this screener that stand out...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/flight-centre-stock-and-2-founder-led-australian-shares-back","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/flight-centre-stock-and-2-founder-led-australian-shares-back","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GEAR.AU","OZF.AU","BK7501","BK7508","XAO.AU","MQG.AU","BK7511","VAP.AU","ZYAU.AU","BK7067","FLT.AU","MSB.AU","IIGF.AU","BBOZ.AU","E200.AU","VAS.AU","BEAR.AU","XJO.AU","BK7042","DACE.AU","QFN.AU","OZR.AU","QRE.AU","BK7043","EIGA.AU","BK7046","STW.AU","XKO.AU","GIVE.AU","SLF.AU","IMLC.AU","MAQ.AU","IISV.AU","BK7070","IOZ.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652401885","title":"Founder Led Australian Stocks With The Clearest Growth Story Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2652401885","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652401885?lang=en_us&edition=fundamental","pubTime":"2026-07-17 16:32","pubTimestamp":1784277172,"startTime":"0","endTime":"0","summary":"With inflation readings, bond yields and energy headlines pulling markets in different directions, many investors are looking for leaders whose interests are tightly aligned with shareholders. Founder-led companies often fit that brief, with executives who have personal capital, reputation and legacy on the line. The Founder-Led Companies screener is built to surface these stocks so you can focus on businesses where leadership tends to think in years, not quarters. In this article, you will...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-australian-stocks-with-the-clearest-growth-story","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-australian-stocks-with-the-clearest-growth-story","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7042","ZYAU.AU","IMLC.AU","BK7046","BBOZ.AU","E200.AU","XKO.AU","SLF.AU","OZF.AU","IOZ.AU","XJO.AU","EIGA.AU","STW.AU","BK7067","VAS.AU","BEAR.AU","BK7511","MAQ.AU","QFN.AU","MQG.AU","FLT.AU","GIVE.AU","MSB.AU","QRE.AU","IISV.AU","DACE.AU","IIGF.AU","VAP.AU","GEAR.AU","OZR.AU","BK7043","XAO.AU","BK7501","BK7070","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652476089","title":"ASX Biggest Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2652476089","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652476089?lang=en_us&edition=fundamental","pubTime":"2026-07-17 10:31","pubTimestamp":1784255502,"startTime":"0","endTime":"0","summary":"Here are the ASX-listed companies with the biggest losses on Friday.EQ Resources : -10%, AU$0.22Mesoblast : -10%, AU$2.50Orezone Gold : -8%, AU$2.07Ora Banda Mining : -8%, AU$0.99Regis Resources : -8%, AU$5.69Sunrise Energy Metals : -7%, AU$15.744DMedical : -7%, AU$3.49Weebit Nano : -7%, AU$6.04Elsight : -7%, AU$6.74Metals X : -7%, AU$1.35","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SRL.AU","MSB.AU","BK7104","BK7069","BK7095","RRL.AU","BK7084","OBM.AU","BK7508","ORE.AU","BK7501","BK7094","BK7067","WBT.AU","BK7098","BK7507","4DX.AU","EQR.AU","ELS.AU","MLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651356415","title":"Founder Led Stocks For Investors Watching Australian Small Caps Closely","url":"https://stock-news.laohu8.com/highlight/detail?id=2651356415","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651356415?lang=en_us&edition=fundamental","pubTime":"2026-07-16 12:44","pubTimestamp":1784177081,"startTime":"0","endTime":"0","summary":"Founder led companies can look especially interesting when inflation, energy costs, and interest rate expectations are pulling markets in different directions. While global data points from US inflation readings to uneven growth in China and mixed signals in Europe keep broad indices on edge, founders often have a large personal stake in long term outcomes. The Founder-Led Companies screener focuses on leaders who built their business and still sit in the driver’s seat. In this article, you...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-for-investors-watching-australian-small-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-for-investors-watching-australian-small-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["E200.AU","DECU","GIVE.AU","FEBU","VOTE","XAO.AU","BK7046","BK7070","BK7042","GEAR.AU","IMLC.AU","OZR.AU","IIGF.AU","IOZ.AU","MAQ.AU","XKO.AU","ISBC","BBOZ.AU","FLT.AU","ZYAU.AU","GXDW","QRE.AU","VGFPF","MQG.AU","STW.AU","SLF.AU","VAP.AU","BK7508","XJO.AU","BK4211","BK7511","MSB.AU","OZF.AU","BK7043","BK7501","BK7067","IISV.AU","BEAR.AU","EIGA.AU","VAS.AU","DACE.AU","QFN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651051480","title":"Flight Centre Stock And 2 Founder Run ASX Shares Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2651051480","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651051480?lang=en_us&edition=fundamental","pubTime":"2026-07-15 08:32","pubTimestamp":1784075557,"startTime":"0","endTime":"0","summary":"When bond yields climb, inflation stays in focus and headlines are dominated by energy security and geopolitical risk, many investors look for leaders with real skin in the game. That is where founder led companies come in. This Founder-Led Companies screener focuses on businesses still guided by the people who built them and who remain personally invested in long term outcomes. This article highlights 3 stocks from the screener that stand out on qualitative grounds and provides a starting...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/flight-centre-stock-and-2-founder-run-asx-shares-worth-a-clo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/flight-centre-stock-and-2-founder-run-asx-shares-worth-a-clo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7511","FLT.AU","BK7067","MSB.AU","BK7046","BK7501","MAQ.AU","BK7043","BK7508","BK7070","BK7042","MQG.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651128502","title":"Mesoblast Achieves Patient Treatment Target in Phase 3 Trial of Chronic Lower Back Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2651128502","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651128502?lang=en_us&edition=fundamental","pubTime":"2026-07-14 08:44","pubTimestamp":1783989850,"startTime":"0","endTime":"0","summary":"Mesoblast (ASX:MSB) achieved its target to treat at least 300 patients in a phase 3 trial of rexlemestrocel-L for chronic lower back pain linked to degenerative disc disease, according to a Tuesday fi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MSB.AU","BK7501","BK7508","MESO","BK4139","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651140024","title":"Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2651140024","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651140024?lang=en_us&edition=fundamental","pubTime":"2026-07-14 08:35","pubTimestamp":1783989339,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUA8RZFJG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","MSB.AU","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651114411","title":"ASX Stocks Estimated To Be Trading Below Fair Value In July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651114411","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651114411?lang=en_us&edition=fundamental","pubTime":"2026-07-14 03:04","pubTimestamp":1783969477,"startTime":"0","endTime":"0","summary":"As tensions in the Middle East escalate, Australian markets are experiencing increased volatility, with energy stocks potentially rising due to climbing oil prices while other sectors may face downward pressure. In such uncertain times, identifying undervalued stocks can be a strategic approach for investors looking to capitalize on potential market inefficiencies and secure long-term value.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-stocks-estimated-to-be-trading-below-fair-value-in-july-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-stocks-estimated-to-be-trading-below-fair-value-in-july-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7023","BK7055","MSB.AU","BK7062","BK7153","BK7067","KGN.AU","XRO.AU","BK7115","LNW.AU","PNV.AU","BK7016","SKS.AU","BK7501","BK7015","BK7503","BK7078","BK7508","LYL.AU","SLC.AU","EOS.AU","BBT.AU","BK7049","BK7002","BK7126","NGI.AU","BK4585","BK4588","NWH.AU","FDV.AU","SPHQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651922061","title":"3 Australian Founder Led Stocks Backed By Strong Long Term Themes","url":"https://stock-news.laohu8.com/highlight/detail?id=2651922061","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651922061?lang=en_us&edition=fundamental","pubTime":"2026-07-13 14:23","pubTimestamp":1783923807,"startTime":"0","endTime":"0","summary":"Founder-led companies sit at an interesting crossroads of today’s markets, where inflation trends, energy costs, and shifting rate expectations regularly reshape sentiment. When a founder still calls the shots, incentives are closely tied to long-term outcomes, which can appeal to investors who want leaders personally committed to the business. This Founder Led Companies screener is designed to highlight stocks where that alignment is clear, regardless of sector. In this article, you will see...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-australian-founder-led-stocks-backed-by-strong-long-term-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-australian-founder-led-stocks-backed-by-strong-long-term-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7043","BK7067","IMLC.AU","QFN.AU","AIPO","IIGF.AU","E200.AU","DACE.AU","BK7046","BK7511","GIVE.AU","XJO.AU","VAP.AU","VAS.AU","BBOZ.AU","BK7070","XKO.AU","MQG.AU","BK7042","IOZ.AU","QRE.AU","GEAR.AU","IISV.AU","MSB.AU","XAO.AU","FLT.AU","OZF.AU","MAQ.AU","EIGA.AU","OZR.AU","BK7501","BEAR.AU","BK7508","SLF.AU","STW.AU","ZYAU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122101526","title":"Stock Track | Mesoblast Soars 8.93% Intraday on Upbeat Ryoncil Cell Therapy Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1122101526","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122101526?lang=en_us&edition=fundamental","pubTime":"2026-07-13 08:50","pubTimestamp":1783903829,"startTime":"0","endTime":"0","summary":"Shares of Mesoblast Ltd (MSB.AU) are soaring, with the stock rising 8.93% during the intraday trading session.The significant price jump follows the company's announcement on Friday that its cell...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651643611","title":"Australia's Mesoblast Extends Gains on Upbeat Ryoncil Cell Therapy Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2651643611","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651643611?lang=en_us&edition=fundamental","pubTime":"2026-07-13 08:47","pubTimestamp":1783903622,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Mesoblast extends gains on upbeat Ryoncil cell therapy earnings** Shares of MesoblastMSB.AXextend gains, rising as much as 9.4% to A$2.45, their highest level since February 27** Stoc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nL4N43F00V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB.AU","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650415750","title":"Founder Led Stocks With Real Skin In The Game","url":"https://stock-news.laohu8.com/highlight/detail?id=2650415750","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650415750?lang=en_us&edition=fundamental","pubTime":"2026-07-12 08:32","pubTimestamp":1783816325,"startTime":"0","endTime":"0","summary":"Founder led companies can offer something many investors value: clear alignment between leadership decisions and long term shareholder interests. With bond yields, inflation readings and energy prices all pulling markets in different directions, some investors are looking for leaders who are deeply tied to the long term outcome of their business, not just the next quarter. This Founder Led Companies screener focuses on stocks where decision makers have a personal legacy on the line. In this...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-with-real-skin-in-the-game","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-with-real-skin-in-the-game","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FLT.AU","BK7501","BK7067","MQG.AU","MSB.AU","BK7043","BK7508","BK7070","BK7042","BK7511","MAQ.AU","BK7046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650157507","title":"Mesoblast (ASX:MSB) Is Up 8.7% After Strong Ryoncil Debut And FDA BLA Milestone - Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2650157507","media":"Simply Wall St.","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650157507?lang=en_us&edition=fundamental","pubTime":"2026-07-12 08:28","pubTimestamp":1783816116,"startTime":"0","endTime":"0","summary":"In July 2026, Mesoblast reported that the FDA had accepted its Biologics License Application for rexlemestrocel‑L in preventing life‑threatening gastrointestinal bleeding in end‑stage heart failure patients with LVADs, while the therapy continued to benefit from Orphan Drug and RMAT designations under newly clarified, more flexible FDA guidance for rare diseases.\nSeparately, Mesoblast disclosed record Ryoncil net revenue of US$36,000,000 for the quarter and US$115,000,000 for its first full...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-is-up-87-after-strong-ryoncil-debut-and-fda","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-is-up-87-after-strong-ryoncil-debut-and-fda","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","BK4585","MSB","LABU","BK4588","BK7067","BK4006","BK7508","MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":185,"code":"91000000","status":"200"}]}}